Director, Global Value Evidence Strategy, Nephrology – Immunology

🕒 2 dias atrás

Candidatar-se

Encontrar Vagas Remotas Similares

Configurar Alerta de Email para Novas Vagas

📊 Verifique sua pontuação de currículo para esta vaga

Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

Enviar Currículo

Otsuka Pharmaceutical Companies (U.S.)

SiteLinkedInTodas as Vagas

1001 - 5000 funcionários

💊 Farmacêutico

🏥 Saúde

🧬 Biotecnologia

Pharmaceuticals • Healthcare • Biotechnology

As Empresas Farmacêuticas Otsuka (EUA) são um ator proeminente na indústria de fabricação farmacêutica, dedicadas a criar produtos inovadores para uma melhor saúde em todo o mundo. A empresa é composta por duas entidades principais: a Otsuka America Pharmaceutical, Inc. (OAPI), que se concentra na comercialização de produtos descobertos e licenciados pela Otsuka na América do Norte, e a Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), que é especializada no desenvolvimento clínico e registro global de soluções inovadoras em saúde, particularmente na área de neurociências.

Descrição

• Lead global value evidence strategy for assigned nephrology/immunology assets • Provide strategic input into integrated evidence plans • Lead evidence generation supporting value demonstration, market access, reimbursement, and patient access objectives • Lead the Value Evidence Sub-Committee for relevant products and indications globally • Coordinate health technology and value evidence input into clinical development programs • Serve on product development and internal/alliance governance committees • Serve as Value Evidence lead for development and maintenance of Integrated Evidence Plans • Develop global value evidence strategies addressing payer, provider, patient, and policymaker evidence needs • Assess health technology assessment needs and track methodological needs • Deliver economic models, real-world evidence, evidence synthesis and meta-analysis, statistical analysis plans, global value dossiers, and AMCP-format dossiers • Coordinate and provide scientific support for non-US HTA submissions with subsidiaries • Lead company responses to US HTA evaluations such as ICER • Develop and generate post-approval real-world evidence with external researchers and experts • Develop publication and communication plans and present/publish value evidence at conferences and peer-reviewed journals

🎯 Requisitos

• Minimum 6 years of relevant pharmaceutical company or payer experience for PhD/MD/PharmD, or 12 years for a Master’s degree • Experience in access, outcomes research, health economics, observational studies, health technology assessment, or a related area • Late-stage drug development and launch experience • Experience with evidence generation in rare diseases • PhD or Master’s degree in health economics, outcomes research, epidemiology, health services research, health policy, pharmaceutical administration, or a related field, or MD or PharmD • Ability to lead global value evidence strategy and evidence-generation programs • Knowledge of payer, provider, patient, and policymaker evidence needs • Experience with economic models, real-world evidence, evidence synthesis, meta-analysis, HTA statistical analysis plans, value dossiers, and AMCP-format dossiers • Experience supporting HTA submissions and responding to HTA evaluations • Ability to develop publication and communication plans and communicate research through conferences and peer-reviewed journals

🏖️ Benefícios

• Incentive opportunity • Comprehensive medical coverage • Dental coverage • Vision coverage • Prescription drug coverage • Company-provided basic life insurance • Accidental death and dismemberment insurance • Short-term disability insurance • Long-term disability insurance • Tuition reimbursement • Student loan assistance • Generous 401(k) match • Flexible time off • Paid holidays • Paid leave programs • Other company-provided benefits